The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Support side: New 13D filer — insiders or holders bought while this setup is live; see the timeline.
Radar 80 (high attention) · dilution pressure elevated · listing risk low · governance risk elevated · runway 1.7 mo · strongest signal: New 13D filer (Sep 3, 2026)
What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.
The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (runway < 6 months) coexists with live selling machinery (shelf filed). Base case is a discounted raise; the question is when, not if.
A fresh shelf is on file with under a year of cash — the ingredients of an offering before the next 10-K. First shelf registration in 12 months filed with ~1.7 months of runway. Companies rarely file a shelf they do not intend to use.
An activist has arrived at a company that needs cash — a potential catalyst, but any financing terms may favour the newcomer. A new active >5% holder appeared while the company is under cash or listing pressure - the classic precursor to a recapitalization, board change, or takeover at a discount.
Nexalin Technology filed two equity-line agreements and an ATM program on August 20 and 21, 2026, simultaneously disclosing a convertible note in an 8-K Item 2.03 (Financial Obligation) and a registered direct offering via prospectus supplement on August 20. The company executed a 1-for-10 reverse split on August 26 and filed a fresh S-1 shelf on September 3. Cash as of June 30, 2026 was $1.0 million against an annualized burn of $7.1 million (1.7 months runway), now 80 days stale. A new Schedule 13D activist appeared September 3.
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 84 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
| Date | Signal | Evidence | Score |
|---|---|---|---|
| Sep 3, 2026 | ▲ New 13D filer | Schedule 13D filed 2026-09-03 filing | 45 |
| Sep 3, 2026 | ▼ Shelf filed | S-1 filed 2026-09-03 filing | 39 |
| Sep 2, 2026 | · Officer/director change | 8-K Item 5.02 filed 2026-09-02 (accepted 16:50 ET) filing | 28 |
| Aug 27, 2026 | ▼ Reverse split | “reverse split” language in 8-K (EX-3.1) filed 2026-08-27 filing | 40 |
| Aug 27, 2026 | ▼ Holder rights modified | 8-K Item 3.03 filed 2026-08-27 (accepted 07:30 ET) filing | 31 |
| Jun 30, 2026 | ▼ Runway < 6 months | ~1.7 months runway: liquidity $1,004,958 as of 2026-06-30, burn $7,126,860/yr (annualized 180-day YTD operating cash flow [companyfacts]) filing | 42 |
SDST Stardust Power Inc. · GOVX GeoVax Labs, Inc. · MYSZ My Size, Inc. · SNTI Senti Biosciences Holdings, · GCTK Glucotrack, Inc. · SOAR Volato Group, Inc. · screener →